Raymond James Financial Services Advisors, Inc. Infinity Pharmaceuticals, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 12, 2020
SELL
$0.88 - $1.29 $10,318 - $15,125
-11,725 Closed
0 $0
Q1 2019

May 06, 2019
SELL
$1.18 - $1.91 $29 - $47
-25 Reduced 0.21%
11,725 $22,000
Q4 2018

Feb 11, 2019
BUY
$1.01 - $2.78 $11,867 - $32,664
11,750 New
11,750 $14,000

Others Institutions Holding INFI

# of Institutions
3
Shares Held
1.26M
Call Options Held
0
Put Options Held
0
View Full List

About INFINITY PHARMACEUTICALS, INC.

INFI Quotes by TradingView
  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email